Clinical Trial

Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-04.
Status change: Not Yet Recruiting → Recruiting 2025-06-16
Trial Details
NCT Number NCT06168292
Lead Sponsor National Cancer Center, Korea
Collaborators: Boston Scientific Corporation
Conditions Biliary Tract Carcinoma, Radiotherapy, Radio-frequency Ablation
Enrollment 53 participants
Start Date 2024-04-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-19